Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome.

doi:10.1016/j.jid.2020.07.026

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome.

The Journal of investigative dermatology - 1 Mar 2021

Quaglino Pietro, Fava Paolo, Pileri Alessandro, Grandi Vieri, Sanlorenzo Martina, Panasiti Vincenzo, Guglielmo Alba, Alberti-Violetti Silvia, Novelli Mauro, Astrua Chiara, Rubatto Marco, Tonella Luca, Berti Emilio, Pimpinelli Nicola, Osella Abate Simona, Fierro Maria Teresa, Vermeer Maarten, Scarisbrick Julia J, Ribero Simone

Abstract excerpt

Primary cutaneous lymphomas encompass a wide spectrum of rare lymphoproliferative disorders originating in the skin, among which, mycosis fungoides (MF) is the most common subtype. The treatment of this disease is based on skin-directed therapies eventually in association with biologic response modifiers in the early phases, whereas in patients with the advanced stages, several therapeutic strategies can be used...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Immunological

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Clinical Trials, Phase III as Topic

Share to Immune Checkpoint Inhibitors

Share to Molecular Targeted Therapy

Share to Mycosis Fungoides

Share to Progression-Free Survival

Share to Randomized Controlled Trials as Topic

Share to Tumor Microenvironment

Source

Open in PubMed

Identifiers

PMID: 33162051
DOI: 10.1016/j.jid.2020.07.026

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome.PMID 33162051Read ↗

Dermatologic Perspectives on Primary Cutaneous Lymphomas: Clinicopathologic Spectrum, Molecular Insights and Evolving Treatment ParadigmsSemantic proximity Read ↗

Cell signaling in cutaneous T‐cell lymphoma microenvironment: promising targets for molecular‐specific treatmentSemantic proximity Read ↗

Mycosis fungoides: an updated review of clinicopathologic variants.Semantic proximity Read ↗

An Update on Molecular Biology of Cutaneous T Cell LymphomaSemantic proximity Read ↗

Determination of T-cell clonality and expression profiles of Toll-like receptors signaling pathway genes and related miRNAs in patients with mycosis fungoidesSemantic proximity Read ↗

Genomic profiling of mycosis fungoides identifies patients at high risk of disease progression.Semantic proximity Read ↗

Primary Cutaneous CD30 positive Lymphoproliferative Disorders—Current Therapeutic Approach with Focus on Brentuximab VedotinSemantic proximity Read ↗

Cutaneous LymphomasSemantic proximity Read ↗

International guidelines for the flow cytometric evaluation of peripheral blood for suspected Sézary syndrome or mycosis fungoides: Assay development/optimization, validation, and ongoing quality monitors.Semantic proximity Read ↗

The mycosis fungoides cutaneous microenvironment shapes dysfunctional cell trafficking, antitumor immunity, matrix interactions, and angiogenesisSemantic proximity Read ↗

The Role of the Immune Phenotype in Tumor Progression and Prognosis of Patients with Mycosis Fungoides: A Quantitative Immunohistology Whole Slide Approach.Semantic proximity Read ↗

Pathogenic variants of mycosis fungoides identified using next-generation sequencing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.